• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国南方超重和肥胖的2型糖尿病患者中非酒精性脂肪性肝病的患病率及风险增加。

Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.

作者信息

Yi M, Chen R-P, Yang R, Chen H

机构信息

Department of Endocrinology, Zhujiang Hospital of Southern Medical University, Guangzhou City, Guangdong Province, China.

出版信息

Diabet Med. 2017 Apr;34(4):505-513. doi: 10.1111/dme.13174. Epub 2016 Sep 15.

DOI:10.1111/dme.13174
PMID:27334577
Abstract

AIMS

To investigate the prevalence of and risk factors for non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes mellitus.

METHODS

We recruited patients with Type 2 diabetes with a BMI ≥ 24 kg/m , who visited the diabetes clinics of 60 hospitals in 21 cities in Guangdong Province, China from August 2011 to March 2012. Anthropometric measurements, biochemical tests and abdominal ultrasonography were performed for all the patients.

RESULTS

The study included 3861 patients (1860 men) with a mean ± sd (range) age of 58.91 ± 13.06 (18-90) years. Non-alcoholic fatty liver disease was found in 1751 patients (45.4%), with a significantly higher prevalence among men than women (48.0 vs 42.9%). The peak of non-alcoholic fatty liver disease prevalence was in patients with a BMI of 34-35 kg/m , those with a triglyceride/HDL cholesterol ratio of 5.5-6.0, men aged < 30 years and women aged 40-50 years. Assessment using the BARD (BMI, aspartate aminotransferase/alanine aminotransferase ratio, diabetes) score system showed that the prevalence of advanced fibrosis was 80.52% in all patients and that women had a higher prevalence than men (86.52 vs 74.16%). Multiple logistic regression analyses showed that dyslipidaemia, BMI and 2-h postprandial plasma glucose were independent risk factors for non-alcoholic fatty liver disease, while heart rate and female gender were protective factors.

CONCLUSION

The prevalence of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China is high. Multiple metabolic disorders were significantly associated with non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes.

摘要

目的

调查超重和肥胖的2型糖尿病患者中非酒精性脂肪性肝病的患病率及危险因素。

方法

我们招募了2011年8月至2012年3月期间在中国广东省21个城市的60家医院糖尿病门诊就诊、BMI≥24 kg/m²的2型糖尿病患者。对所有患者进行人体测量、生化检测和腹部超声检查。

结果

该研究纳入了3861例患者(1860例男性),平均年龄±标准差(范围)为58.91±13.06(18 - 90)岁。1751例患者(45.4%)被诊断为非酒精性脂肪性肝病,男性患病率显著高于女性(48.0%对42.9%)。非酒精性脂肪性肝病患病率的高峰出现在BMI为34 - 35 kg/m²、甘油三酯/高密度脂蛋白胆固醇比值为5.5 - 6.0、年龄<30岁的男性以及40 - 50岁的女性患者中。使用BARD(BMI、天冬氨酸转氨酶/丙氨酸转氨酶比值、糖尿病)评分系统评估显示,所有患者中晚期纤维化的患病率为80.52%,女性患病率高于男性(86.52%对74.16%)。多因素逻辑回归分析显示,血脂异常、BMI和餐后2小时血糖是非酒精性脂肪性肝病的独立危险因素,而心率和女性性别是保护因素。

结论

中国南方超重和肥胖的2型糖尿病患者中非酒精性脂肪性肝病的患病率较高。多种代谢紊乱与超重和肥胖的2型糖尿病患者的非酒精性脂肪性肝病显著相关。

相似文献

1
Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.中国南方超重和肥胖的2型糖尿病患者中非酒精性脂肪性肝病的患病率及风险增加。
Diabet Med. 2017 Apr;34(4):505-513. doi: 10.1111/dme.13174. Epub 2016 Sep 15.
2
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
3
Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.不同年龄和体重指数女性非酒精性脂肪性肝病及其代谢危险因素的患病率
Menopause. 2015 Jun;22(6):667-73. doi: 10.1097/GME.0000000000000352.
4
Prevalence and associated metabolic factors of fatty liver disease in the elderly.老年人脂肪肝的患病率及相关代谢因素。
Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27.
5
Study of Clinical Profile of Patients of Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome.非酒精性脂肪性肝病患者的临床特征及其与代谢综合征的关联研究
J Assoc Physicians India. 2015 Jan;63(1):12-6.
6
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
7
[Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].超重和肥胖儿童及青少年中的非酒精性脂肪性肝病
Med Clin (Barc). 2015 Jan 20;144(2):55-8. doi: 10.1016/j.medcli.2014.02.018. Epub 2014 Apr 24.
8
Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.中国人群非酒精性脂肪性肝病的患病率及危险因素:一项8年随访研究
World J Gastroenterol. 2016 Apr 7;22(13):3663-9. doi: 10.3748/wjg.v22.i13.3663.
9
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).脂肪肝指数可预测前驱糖尿病、2型糖尿病和非酒精性脂肪性肝病(NAFLD)的发病风险。
Ann Med. 2021 Dec;53(1):1256-1264. doi: 10.1080/07853890.2021.1956685.
10
Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.非酒精性脂肪肝和体型表型对糖尿病风险的综合影响。
Cardiovasc Diabetol. 2015 Oct 29;14:144. doi: 10.1186/s12933-015-0306-0.

引用本文的文献

1
High Prevalence of Fatty Liver in Bangladeshi Adolescents and Young Adults with Type 2 Diabetes: Key Predictors and Screening Recommendations.孟加拉国2型糖尿病青少年和青年中脂肪肝的高患病率:关键预测因素及筛查建议
Diabetes Metab Syndr Obes. 2025 Jun 24;18:2019-2027. doi: 10.2147/DMSO.S520806. eCollection 2025.
2
The association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in US adults.美国成年人中估计的葡萄糖处置率与代谢功能障碍相关脂肪性肝病及肝纤维化之间的关联。
BMC Endocr Disord. 2025 Mar 11;25(1):67. doi: 10.1186/s12902-025-01891-7.
3
Correlation between qualitative and semi-quantitative ultrasound assessment of diffuse fatty liver disease: A case-control study.
弥漫性脂肪肝疾病的定性与半定量超声评估之间的相关性:一项病例对照研究。
Ultrasound. 2024 Nov;32(4):253-259. doi: 10.1177/1742271X241241779. Epub 2024 Apr 11.
4
Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021.204 个国家和地区 1990 年至 2021 年归因于空腹血糖升高的代谢功能障碍相关脂肪性肝病的全球负担。
Sci Rep. 2024 Sep 27;14(1):22232. doi: 10.1038/s41598-024-72795-0.
5
Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice.ADAR2 缺乏通过 AMPK 信号通路改善肥胖小鼠的代谢相关脂肪性肝病。
Commun Biol. 2024 May 17;7(1):594. doi: 10.1038/s42003-024-06215-4.
6
Gender differences in the ideal cutoffs of visceral fat area for predicting MAFLD in China.中国人群内脏脂肪面积预测 MAFLD 的理想切点的性别差异。
Lipids Health Dis. 2022 Dec 31;21(1):148. doi: 10.1186/s12944-022-01763-2.
7
Gender Differences in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的性别差异
Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S19-S25. doi: 10.5005/jp-journals-10018-1370.
8
Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study.在FIB-4肝纤维化评分中加入透明质酸可改善2型糖尿病患者发生肝硬化和肝细胞癌的预测:爱丁堡2型糖尿病研究
Obes Sci Pract. 2021 May 6;7(5):497-508. doi: 10.1002/osp4.484. eCollection 2021 Oct.
9
Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus.非酒精性脂肪性肝病及其与糖尿病的关联。
Cureus. 2021 Aug 20;13(8):e17321. doi: 10.7759/cureus.17321. eCollection 2021 Aug.
10
Prevalence of fatty liver disease and its associated factors among Jordanian patients with type 2 diabetes mellitus: A cross-sectional study.约旦2型糖尿病患者中脂肪肝疾病的患病率及其相关因素:一项横断面研究。
Ann Med Surg (Lond). 2021 Aug 6;68:102677. doi: 10.1016/j.amsu.2021.102677. eCollection 2021 Aug.